This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
Zacks News
MGIC Investment (MTG) Q2 Earnings Surpass Estimates
by Zacks Equity Research
MGIC (MTG) delivered earnings and revenue surprises of +17.14% and -0.35%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
Zeta (ZETA) Surges 12.6%: Is This an Indication of Further Gains?
by Zacks Equity Research
Zeta (ZETA) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.
Lemonade (LMND) Moves 9.4% Higher: Will This Strength Last?
by Zacks Equity Research
Lemonade (LMND) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock suggests that there could be more strength down the road.
Tango Therapeutics (TNGX) Moves 7.5% Higher: Will This Strength Last?
by Zacks Equity Research
Tango Therapeutics (TNGX) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock suggests that there could be more strength down the road.
International General Insurance Holdings Ltd. (IGIC) Q1 Earnings and Revenues Miss Estimates
by Zacks Equity Research
International General Insurance (IGIC) delivered earnings and revenue surprises of -10.64% and 4.80%, respectively, for the quarter ended March 2025. Do the numbers hold clues to what lies ahead for the stock?
MetLife (MET) Lags Q1 Earnings Estimates
by Zacks Equity Research
MetLife (MET) delivered earnings and revenue surprises of -1.51% and 3.40%, respectively, for the quarter ended March 2025. Do the numbers hold clues to what lies ahead for the stock?
Analysts Estimate International General Insurance Holdings Ltd. (IGIC) to Report a Decline in Earnings: What to Look Out for
by Zacks Equity Research
International General Insurance (IGIC) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Strength Seen in International General Insurance (IGIC): Can Its 5.4% Jump Turn into More Strength?
by Zacks Equity Research
International General Insurance (IGIC) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term.
EverQuote (EVER) Q4 Earnings and Revenues Top Estimates
by Zacks Equity Research
EverQuote (EVER) delivered earnings and revenue surprises of 83.33% and 10%, respectively, for the quarter ended December 2024. Do the numbers hold clues to what lies ahead for the stock?
Horace Mann (HMN) Q4 Earnings Surpass Estimates
by Zacks Equity Research
Horace Mann (HMN) delivered earnings and revenue surprises of 63.64% and 2.48%, respectively, for the quarter ended December 2024. Do the numbers hold clues to what lies ahead for the stock?